The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer

被引:23
作者
Castro, Elena [1 ,2 ]
Mikropoulos, Christos [1 ,2 ]
Bancroft, Elizabeth K. [1 ,2 ]
Dadaev, Tokhir [1 ]
Goh, Chee [1 ,2 ]
Taylor, Natalie [1 ,2 ]
Saunders, Edward [1 ]
Borley, Nigel [2 ]
Keating, Diana [1 ]
Page, Elizabeth C. [1 ]
Saya, Sibel [1 ]
Hazell, Stephen [3 ]
Livni, Naomi [3 ]
deSouza, Nandita [4 ]
Neal, David [5 ,6 ]
Hamdy, Freddie C. [7 ]
Kumar, Pardeep [2 ]
Antoniou, Antonis C. [8 ]
Kote-Jarai, Zsofia [1 ]
Eeles, Rosalind A. [1 ,2 ]
机构
[1] Inst Canc Res, Oncogenet Team, London SW3 6JB, England
[2] Royal Marsden Natl Hlth Serv Fdn Trust, Acad Urol Unit, London, England
[3] Royal Marsden Natl Hlth Serv Fdn Trust, Histopathol Dept, London, England
[4] Inst Canc Res, Div Radiotherapy & Imaging, Sutton SM2 5NG, Surrey, England
[5] Canc Res UK Cambridge Inst, Dept Oncol, Cambridge, England
[6] Canc Res UK Cambridge Inst, Dept Surg, Cambridge, England
[7] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England
[8] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England
基金
加拿大健康研究院;
关键词
Prostate cancer; Family history; Single nucleotide polymorphisms; Prostate-specific antigen; GENETIC-VARIANTS; RISK; ANTIGEN; PREVALENCE; MARKERS; UTILITY; IMPACT;
D O I
10.1634/theoncologist.2015-0336
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. A better assessment of individualized prostate cancer (PrCa) risk is needed to improve screening. The use of the prostate-specific antigen (PSA) level for screening in the general population has limitations and is not currently advocated. Approximately 100 common single nucleotide polymorphisms (SNPs) have been identified that are associated with the risk of developing PrCa. The PROFILE pilot study explored the feasibility of using SNP profiling in men with a family history (FH) of PrCa to investigate the probability of detecting PrCa at prostate biopsy (PB). The primary aim of this pilot study was to determine the safety and feasibility of PrCa screening using transrectal ultrasound-guided PB with or without diffusion-weighted magnetic resonance imaging (DW-MRI) in men with a FH. A secondary aim was to evaluate the potential use of SNP profiling as a screening tool in this population. Patients and Methods. A total of 100 men aged 40-69 years with a FH of PrCa underwent PB, regardless of their baseline PSA level. Polygenic risk scores (PRSs) were calculated for each participant using 71 common PrCa susceptibility alleles. We treated the disease outcome at PB as the outcome variable and evaluated its associations with the PRS, PSA level, and DW-MRI findings using univariate logistic regression. Results. Of the 100 men, 25 were diagnosed with PrCa, of whom 12 (48%) had clinically significant disease. Four adverse events occurred and no deaths. The PSA level and age at study entry were associated with PrCa at PB (p = .00037 and p = .00004, respectively). Conclusion. The results of the present pilot study have demonstrated that PB is a feasible and safe method of PrCa screening in men with a FH, with a high proportion of PrCa identified requiring radical treatment. It is feasible to collect data on PrCa-risk SNPs to evaluate their combined effect as a potential screening tool. A larger prospective study powered to detect statistical associations is in progress.
引用
收藏
页码:716 / 722
页数:7
相关论文
共 26 条
[1]   Reproducibility, Performance, and Clinical Utility of a Genetic Risk Prediction Model for Prostate Cancer in Japanese [J].
Akamatsu, Shusuke ;
Takahashi, Atsushi ;
Takata, Ryo ;
Kubo, Michiaki ;
Inoue, Takahiro ;
Morizono, Takashi ;
Tsunoda, Tatsuhiko ;
Kamatani, Naoyuki ;
Haiman, Christopher A. ;
Wan, Peggy ;
Chen, Gary K. ;
Le Marchand, Loic ;
Kolonel, Laurence N. ;
Henderson, Brian E. ;
Fujioka, Tomoaki ;
Habuchi, Tomonori ;
Nakamura, Yusuke ;
Ogawa, Osamu ;
Nakagawa, Hidewaki .
PLOS ONE, 2012, 7 (10)
[2]   PSA screening and prostate cancer risk reduction [J].
Andriole, Gerry L., Jr. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (06) :936-937
[3]  
[Anonymous], 2014, R LANG ENV STAT COMP
[4]   iCOGS collection provides a collaborative model FOREWORD [J].
Bahcall, Orli G. .
NATURE GENETICS, 2013, 45 (04) :343-343
[5]   Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion [J].
Basch, Ethan ;
Oliver, Thomas K. ;
Vickers, Andrew ;
Thompson, Ian ;
Kantoff, Philip ;
Parnes, Howard ;
Loblaw, D. Andrew ;
Roth, Bruce ;
Williams, James ;
Nam, Robert K. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (24) :3020-3025
[6]   Prostate Cancer Screening: Facts, Statistics, and Interpretation in Response to the US Preventive Services Task Force Review [J].
Carlsson, Sigrid ;
Vickers, Andrew J. ;
Roobol, Monique ;
Eastham, James ;
Scardino, Peter ;
Lilja, Hans ;
Hugosson, Jonas .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) :2581-2584
[7]   Diffusion-weighted MRI for detecting prostate tumour in men at increased genetic risk [J].
deSouza, Nandita M. ;
Morgan, Veronica A. ;
Bancroft, Elizabeth ;
Sohaib, S. Aslam ;
Giles, Sharon L. ;
Kote-Jarai, Zsofia ;
Castro, Elena ;
Hazell, Steven ;
Jafar, Maysam ;
Eeles, Rosalind .
EUROPEAN JOURNAL OF RADIOLOGY OPEN, 2014, 1 :22-27
[8]   The genetic epidemiology of prostate cancer and its clinical implications [J].
Eeles, Rosalind ;
Goh, Chee ;
Castro, Elena ;
Bancroft, Elizabeth ;
Guy, Michelle ;
Al Olama, Ali Amin ;
Easton, Douglas ;
Kote-Jarai, Zsofia .
NATURE REVIEWS UROLOGY, 2014, 11 (01) :18-31
[9]   Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array [J].
Eeles, Rosalind A. ;
Al Olama, Ali Amin ;
Benlloch, Sara ;
Saunders, Edward J. ;
Leongamornlert, Daniel A. ;
Tymrakiewicz, Malgorzata ;
Ghoussaini, Maya ;
Luccarini, Craig ;
Dennis, Joe ;
Jugurnauth-Little, Sarah ;
Dadaev, Tokhir ;
Neal, David E. ;
Hamdy, Freddie C. ;
Donovan, Jenny L. ;
Muir, Ken ;
Giles, Graham G. ;
Severi, Gianluca ;
Wiklund, Fredrik ;
Gronberg, Henrik ;
Haiman, Christopher A. ;
Schumacher, Fredrick ;
Henderson, Brian E. ;
Le Marchand, Loic ;
Lindstrom, Sara ;
Kraft, Peter ;
Hunter, David J. ;
Gapstur, Susan ;
Chanock, Stephen J. ;
Berndt, Sonja I. ;
Albanes, Demetrius ;
Andriole, Gerald ;
Schleutker, Johanna ;
Weischer, Maren ;
Canzian, Federico ;
Riboli, Elio ;
Key, Tim J. ;
Travis, Ruth C. ;
Campa, Daniele ;
Ingles, Sue A. ;
John, Esther M. ;
Hayes, Richard B. ;
Pharoah, Paul D. P. ;
Pashayan, Nora ;
Khaw, Kay-Tee ;
Stanford, Janet L. ;
Ostrander, Elaine A. ;
Signorello, Lisa B. ;
Thibodeau, Stephen N. ;
Schaid, Dan ;
Maier, Christiane .
NATURE GENETICS, 2013, 45 (04) :385-391
[10]   Cancer risk prediction models: A workshop on development, evaluation, and application [J].
Freedman, AN ;
Seminara, D ;
Gail, MH ;
Hartge, P ;
Colditz, GA ;
Ballard-Barbash, R ;
Pfeiffer, RM .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (10) :715-723